Status:
COMPLETED
Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Cardiac Surgical Procedures
Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar leve...
Detailed Description
Rigorous intraoperative glycemic control may be of paramount importance in affecting outcomes after cardiac surgery. There is evidence that strict control of glucose levels postoperatively results in ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All subjects accepted for this study must be:
- \>=18 years of age
- Undergoing an elective cardiac surgical procedure
- Exclusion Criteria
- Subjects who have one or more of the following will be excluded from the study:
- Undergoing surgery not utilizing cardiopulmonary bypass
- Unable to grant informed consent or comply with study procedure
- Undergoing emergency open heart-surgery
- 3\. Are allergic to any of the excipients in insulin
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00282698
Start Date
July 1 2004
End Date
May 1 2005
Last Update
May 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905